LONDON, April 16 Drugmaker GlaxoSmithKline
said on Wednesday it was investigating allegations of
bribery involving some of its staff in Jordan and Lebanon,
following earlier claims of corruption in China, Iraq and
"GSK can confirm we are investigating allegations regarding
the activity of a small number of individuals in our operations
in Jordan and Lebanon," the company said in statement.
"We started investigating using internal and external teams
as soon as we became aware of these claims. These investigations
have not yet concluded."
(Reporting by Ben Hirschler; Editing by Greg Mahlich)